{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:13:46Z","timestamp":1794276826265,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["468853597"],"award-info":[{"award-number":["468853597"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82161138021"],"award-info":[{"award-number":["82161138021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.euroneuro.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T02:26:47Z","timestamp":1710469607000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Dongfang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-9532","authenticated-orcid":false,"given":"Johannes","family":"Schneider-Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-2039","authenticated-orcid":false,"given":"Spyridon","family":"Siafis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7596-0979","authenticated-orcid":false,"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2024.03.003_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eurpsy.2004.11.003","article-title":"Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies","volume":"20","author":"Abi-Dargham","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-9964(98)00146-7","article-title":"Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and \u03b11-adrenergic receptors in vitro","volume":"37","author":"Bymaster","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0003","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"2020","author":"Ceraso","year":"2020","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Collaborators","year":"2022","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview","volume":"35","author":"Correll","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0006","article-title":"A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia","author":"Dong","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010919","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ open"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40263-013-0062-1","article-title":"The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain","volume":"27","author":"He","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1162\/0899766054026675","article-title":"Cognitive enhancement mediated through postsynaptic actions of norepinephrine on ongoing cortical activity","volume":"17","author":"Hoshino","year":"2005","journal-title":"Neural Comput"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0012","first-page":"443","article-title":"Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis","volume":"18","author":"Huhn","year":"2020","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre\u2013post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2023.03.007","article-title":"Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study","author":"Koch","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0079-6123(08)00910-2","article-title":"Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin\u2013dopamine hypothesis. Prog","volume":"172","author":"Kuroki","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0017","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4088\/JCP.v69n0512","article-title":"An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia","volume":"69","author":"Lauriello","year":"2008","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2022.01.001","article-title":"About the issue of including or excluding studies from China in systematic reviews","volume":"240","author":"Leucht","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/wps.21089","article-title":"Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis","volume":"22","author":"Leucht","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0021","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-022-02027-4","article-title":"Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis","volume":"12","author":"Lu","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0022","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1017\/S0140525X15000667","article-title":"Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory","volume":"39","author":"Mather","year":"2016","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0024","article-title":"The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling","author":"Overall","year":"1988","journal-title":"Psychopharmacology bulletin"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0025","article-title":"China vows to clamp down on academic fraud amid medical journal scandal","volume":"357","author":"Parry","year":"2017","journal-title":"BMJ: British Medical Journal (Online)"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1389200217666151210125831","article-title":"Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs","volume":"17","author":"Ragia","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0027","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-3223(99)00127-4","article-title":"Role of norepinephrine in the pathophysiology and treatment of mood disorders","volume":"46","author":"Ressler","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0028","volume":"2019","author":"R\u00fccker","year":"2016"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0029","series-title":"Network Meta-Analysis, Systematic Reviews in Health Research: Meta-Analysis in Context","first-page":"238","author":"Salanti","year":"2022"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0030","first-page":"17","article-title":"Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents","volume":"9","author":"Sheehan","year":"2012","journal-title":"Innovations in Clinical Neuroscience"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0031","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.euroneuro.2023.04.015","article-title":"Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable","volume":"73","author":"Stahl","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0554-2","article-title":"Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0033","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12874-021-01401-y","article-title":"Prevalence of evidence of inconsistency and its association with network structural characteristics in 201 published networks of interventions","volume":"21","author":"Veroniki","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0034","article-title":"Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials","author":"Wang","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.euroneuro.2024.03.003_bib0036","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:14:10Z","timestamp":1717794850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0924977X24000610"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.03.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}